Standard Biotools annual gross margin
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2022
2023
2024
2025
Standard Biotools Gross Margin Growth & History (LAB)
Standard Biotools's gross margin was 49.86% for fiscal 2025.
View full Standard Biotools company overviewStandard Biotools annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 49.86% | +0.54 pp |
| 2024 | 2024-12-31 | 49.32% | +1.88 pp |
| 2023 | 2023-12-31 | 47.44% | +9.61 pp |
| 2022 | 2022-12-31 | 37.83% | — |
| 2019 | 2019-12-31 | 54.83% | +0.25 pp |
| 2018 | 2018-12-31 | 54.57% | +3.58 pp |
| 2017 | 2017-12-31 | 50.99% | −4.96 pp |
| 2016 | 2016-12-31 | 55.95% | −43.79 pp |
| 2015 | 2015-12-31 | 99.74% | −0.00 pp |
| 2014 | 2014-12-31 | 99.74% | +0.16 pp |
| 2013 | 2013-12-31 | 99.58% | +0.15 pp |
| 2012 | 2012-12-31 | 99.43% | −0.34 pp |
| 2011 | 2011-12-31 | 99.77% | +34.28 pp |
| 2010 | 2010-12-31 | 65.49% | +10.69 pp |
| 2009 | 2009-12-31 | 54.80% | — |
Standard Biotools quarterly gross margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 52.40% | +3.57 pp |
| Q1 2026 | 2026-03-31 | 53.48% | −1.16 pp |
| Q4 2025 | 2025-12-31 | 47.83% | +250.64 pp |
| Q3 2025 | 2025-09-30 | 48.51% | −6.40 pp |
| Q2 2025 | 2025-06-30 | 48.84% | +2.71 pp |
| Q1 2025 | 2025-03-31 | 54.64% | +1.52 pp |
| Q4 2024 | 2024-12-31 | −202.81% | −250.39 pp |
| Q3 2024 | 2024-09-30 | 54.90% | +10.93 pp |
| Q2 2024 | 2024-06-30 | 46.12% | −3.04 pp |
| Q1 2024 | 2024-03-31 | 53.11% | +4.22 pp |
| Q4 2023 | 2023-12-31 | 47.58% | — |
| Q3 2023 | 2023-09-30 | 43.97% | +8.02 pp |
| Q2 2023 | 2023-06-30 | 49.17% | +25.59 pp |
| Q1 2023 | 2023-03-31 | 48.89% | — |
| Q3 2022 | 2022-09-30 | 35.95% | — |
| Q2 2022 | 2022-06-30 | 23.58% | — |
| Q4 2020 | 2020-12-31 | 49.50% | −4.57 pp |
| Q3 2020 | 2020-09-30 | 52.18% | −0.05 pp |
| Q2 2020 | 2020-06-30 | 45.38% | −9.11 pp |
| Q1 2020 | 2020-03-31 | 47.08% | −9.34 pp |
| Q4 2019 | 2019-12-31 | 54.06% | −4.13 pp |
| Q3 2019 | 2019-09-30 | 52.23% | −2.40 pp |
| Q2 2019 | 2019-06-30 | 54.49% | +3.07 pp |
| Q1 2019 | 2019-03-31 | 56.42% | +3.24 pp |
| Q4 2018 | 2018-12-31 | 58.19% | +19.09 pp |
| Q3 2018 | 2018-09-30 | 54.63% | +0.75 pp |
| Q2 2018 | 2018-06-30 | 51.42% | −3.44 pp |
| Q1 2018 | 2018-03-31 | 53.18% | −4.32 pp |
| Q4 2017 | 2017-12-31 | 39.10% | −1.45 pp |
| Q3 2017 | 2017-09-30 | 53.88% | −5.25 pp |
| Q2 2017 | 2017-06-30 | 54.86% | −5.24 pp |
| Q1 2017 | 2017-03-31 | 57.50% | −5.31 pp |
| Q4 2016 | 2016-12-31 | 40.55% | −161.04 pp |
| Q3 2016 | 2016-09-30 | 59.12% | −4.35 pp |
| Q2 2016 | 2016-06-30 | 60.10% | −0.92 pp |
| Q1 2016 | 2016-03-31 | 62.81% | −0.18 pp |
| Q4 2015 | 2015-12-31 | 201.59% | +15.25 pp |
| Q3 2015 | 2015-09-30 | 63.47% | −0.90 pp |
| Q2 2015 | 2015-06-30 | 61.02% | −2.92 pp |
| Q1 2015 | 2015-03-31 | 62.99% | −3.18 pp |
| Q4 2014 | 2014-12-31 | 186.35% | +19.43 pp |
| Q3 2014 | 2014-09-30 | 64.37% | −7.53 pp |
| Q2 2014 | 2014-06-30 | 63.94% | −8.16 pp |
| Q1 2014 | 2014-03-31 | 66.16% | −4.53 pp |
| Q4 2013 | 2013-12-31 | 166.92% | −1.35 pp |
| Q3 2013 | 2013-09-30 | 71.90% | −0.57 pp |
| Q2 2013 | 2013-06-30 | 72.11% | +2.43 pp |
| Q1 2013 | 2013-03-31 | 70.70% | +3.10 pp |
| Q4 2012 | 2012-12-31 | 168.27% | −1.62 pp |
| Q3 2012 | 2012-09-30 | 72.48% | +3.67 pp |
| Q2 2012 | 2012-06-30 | 69.68% | −2.29 pp |
| Q1 2012 | 2012-03-31 | 67.60% | +1.10 pp |
| Q4 2011 | 2011-12-31 | 169.89% | — |
| Q3 2011 | 2011-09-30 | 68.81% | −2.20 pp |
| Q2 2011 | 2011-06-30 | 71.96% | +8.11 pp |
| Q1 2011 | 2011-03-31 | 66.51% | — |
| Q3 2010 | 2010-09-30 | 71.01% | — |
| Q2 2010 | 2010-06-30 | 63.85% | — |
Standard Biotools gross margin trends
Between the periods ended 2009-12-31 and 2025-12-31, Standard Biotools's gross margin decreased from 54.80% to 49.86%, a change of −4.94 percentage points. The latest reported quarter, Q2 2026, shows 52.40%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Standard Biotools source filings ↗